[go: up one dir, main page]

WO2011150393A9 - Methods for improving maternal and fetal health - Google Patents

Methods for improving maternal and fetal health Download PDF

Info

Publication number
WO2011150393A9
WO2011150393A9 PCT/US2011/038438 US2011038438W WO2011150393A9 WO 2011150393 A9 WO2011150393 A9 WO 2011150393A9 US 2011038438 W US2011038438 W US 2011038438W WO 2011150393 A9 WO2011150393 A9 WO 2011150393A9
Authority
WO
WIPO (PCT)
Prior art keywords
methods
fetal health
maternal
improving maternal
improving
Prior art date
Application number
PCT/US2011/038438
Other languages
French (fr)
Other versions
WO2011150393A2 (en
Inventor
Rosalba Paesano
Jeffrey L. Lillard
William A. Goolsbee
Piera Valenti
Miriam Pietropaoli
Original Assignee
Bmg Hematology Llc
Microbo S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bmg Hematology Llc, Microbo S.R.L. filed Critical Bmg Hematology Llc
Publication of WO2011150393A2 publication Critical patent/WO2011150393A2/en
Publication of WO2011150393A9 publication Critical patent/WO2011150393A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/US2011/038438 2010-05-28 2011-05-27 Methods for improving maternal and fetal health WO2011150393A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34966610P 2010-05-28 2010-05-28
US61/349,666 2010-05-28
US42398210P 2010-12-16 2010-12-16
US61/423,982 2010-12-16

Publications (2)

Publication Number Publication Date
WO2011150393A2 WO2011150393A2 (en) 2011-12-01
WO2011150393A9 true WO2011150393A9 (en) 2012-03-08

Family

ID=45004884

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/038438 WO2011150393A2 (en) 2010-05-28 2011-05-27 Methods for improving maternal and fetal health

Country Status (1)

Country Link
WO (1) WO2011150393A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20122151A1 (en) * 2012-12-17 2014-06-18 Progine Farmaceutici S R L ANTI-BURIAL PREPARATION.
ITMI20122152A1 (en) * 2012-12-17 2014-06-18 Progine Farmaceutici S R L COMPOSITION FOR TOPICAL USE.
CN103550760A (en) * 2013-11-07 2014-02-05 无锡科捷诺生物科技有限责任公司 Application of lactoferrin in preparing medicine for treating anemia of adipose people with high inflammatory factors
RU2016132884A (en) * 2014-01-10 2018-02-14 Нестек С.А. INTRODUCTION OF VITAMIN B6 MOTHER FOR PREVENTION OF INCREASED OBESITY, OVERWEIGHT OR OBESITY AT CELEBRITY
WO2016056665A1 (en) * 2014-10-08 2016-04-14 学校法人慶應義塾 White blood cell extracellular trap formation inhibitor
RU2632435C1 (en) * 2016-09-12 2017-10-04 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Method of personalized administration of pregnancy with infectious pathology of urogenital tract at early terms of gestation
CN111257445B (en) * 2020-01-22 2022-09-09 上海交通大学医学院附属仁济医院 Product and method for SLE pregnant woman disease monitoring and fetus outcome prediction
IT202100013898A1 (en) 2021-05-27 2022-11-27 Hulka S R L Composition comprising an alpha-tocopherol ester for the reduction of the risk of preterm birth
AR131918A1 (en) * 2023-02-22 2025-05-14 Lactea Therapeutics Llc COMPOSITIONS OF PURIFIED LACTOFERRIN AND METHODS OF USE
CN116253805B (en) * 2023-03-23 2023-10-24 深圳霁因生物医药转化研究院 Polypeptide, hydrogel and application
US12219981B1 (en) * 2024-05-22 2025-02-11 Phoenix Creative Nutraceuticals, LLC Methods and compositions to assist and support the formation of red blood cells and hemoglobin

Also Published As

Publication number Publication date
WO2011150393A2 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
WO2011150393A9 (en) Methods for improving maternal and fetal health
EP2893060A4 (en) Methods for increasing fetal fraction in maternal blood
GB2479476B (en) Simultaneous determination of aneuploidy and fetal fraction
EP2866698B8 (en) Ultrasonic surgical instruments with distally positioned jaw assemblies
EP2527828A4 (en) Ultrasound probe
IL215802A0 (en) Diagnostic devices and related methods
EP2421442A4 (en) Fetal monitoring device and methods
EP2600783A4 (en) Systems and methods for ultrasound treatment
PL2529032T3 (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
EP2614776A4 (en) Ultrasound diagnostic equipment
GB201011971D0 (en) Methods and product
EP2389573A4 (en) Skin analysis methods
EP2490019A4 (en) Examination device and examination method
EP2638721A4 (en) Methods and devices for providing measurement reports
EP2538849A4 (en) Surgical articles and methods
GB201008541D0 (en) Diagnostic methods
EP2626009A4 (en) Ultrasonic diagnostic device and ultrasonic diagnostic method
EP2527004A4 (en) Ultrasound probe
EP2565622A4 (en) Method and device for measuring scattering-absorption body
ZA201208687B (en) Obstetric forceps
WO2011137456A9 (en) Methods and mechanisms involving hyperpigmentation particularly for african american skin
GB201016373D0 (en) Birthing aid
HK1162197B (en) Simultaneous determination of aneuploidy and fetal fraction
AU2010901351A0 (en) Diagnostic and prognostic methods
AU2010901649A0 (en) Method for improving the health of skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11787540

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11787540

Country of ref document: EP

Kind code of ref document: A2